
Suma10 mg/spra
ACME Laboratories Ltd.
Sumatriptan is a triptan medicine used for the acute (abortive) treatment of certain headache disorders.
Sumatriptan is a triptan medicine used for the acute (abortive) treatment of certain headache disorders. It does not prevent attacks and is not for daily/prophylactic use.
| Indication | Evidence / Status | Formulation typically used |
|---|---|---|
| Acute treatment of migraine attacks, with or without aura, in adults | Established / FDA-approved | Oral tablet, subcutaneous injection, nasal spray |
| Acute treatment of migraine attacks in adolescents (12–17 years) | FDA-approved for this formulation only | Nasal spray |
| Acute treatment of cluster headache episodes in adults | Established / FDA-approved | Subcutaneous injection |
Sumatriptan is not indicated for prevention (prophylaxis) of migraine, for hemiplegic or basilar migraine, or for tension-type or other non-migraine headaches.
| Formulation | Usual single dose | Repeat dosing | Maximum |
|---|---|---|---|
| Oral tablet | 25 mg, 50 mg, or 100 mg | May repeat once after ≥2 hours if migraine returns | 200 mg per 24 hours |
| Subcutaneous injection | 4 mg or 6 mg | May repeat once after ≥1 hour if migraine returns | 12 mg (two 6 mg doses) per 24 hours |
| Nasal spray | 5 mg, 10 mg, or 20 mg in one nostril | May repeat once after ≥2 hours if migraine returns | 40 mg per 24 hours |
Subcutaneous injection 6 mg for an acute episode; may repeat once after at least 1 hour if needed. Maximum 12 mg (two 6 mg injections) in 24 hours. Oral and nasal forms are not established for cluster headache.
Nasal spray only: a single 10 mg or 20 mg spray in one nostril, based on body weight, at the onset of migraine. The safety and effectiveness of a second dose in this age group have not been established (see Pediatric Uses).
In mild-to-moderate hepatic impairment, use the lowest recommended dose and monitor closely. Sumatriptan is not recommended in severe hepatic impairment (see Contraindications).
Doses should be taken as early as possible after migraine symptom onset, but Sumatriptan is effective when taken at any point during an attack. Do not use for a headache with atypical features suggestive of stroke or other serious neurological cause without medical evaluation.
Common side effects of Sumatriptan include:
Rare but serious effects — including cardiac ischemia, stroke, serotonin syndrome, seizures, and anaphylaxis — are discussed under Precautions and Warnings.
Sumatriptan is contraindicated in patients with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.